课题基金 / 基金详情

项目摘要

项目成果

William Russell Renthal的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要(多组学核心) 单细胞转录组学是PRECISION人类疼痛网络的核心组成部分, 强大的新工具为理解细胞类型、分子和细胞- 导致慢性疼痛的细胞相互作用。多组学核心将由Renthal博士领导, 单细胞转录组学,表观基因组学和下一代测序工作与经验丰富的团队, 单细胞和下一代测序工作的开发、优化和分析。的 这些尖端技术的集中化将确保已建立的协议能够得到应用 系统地对中心的所有样本进行检测。具体来说,核心将提供单细胞和单核 多组学服务,以表征项目1和2中的疼痛相关组织。然后,他们将提供两个 项目快速的下一代测序服务,1-3天的周转时间以成本计算。最后,核心将 保持在快速发展的单细胞基因组学领域的前沿,并继续带来创新 提高质量,降低成本,回到中心。核心还将与其他类似的核心协调, U19 PRECISION人类疼痛网络,以协调协议和最佳实践。
英文摘要
PROJECT SUMMARY (Multi-omics Core) Single-cell transcriptomics is a central component of the PRECISION Human Pain Network because these powerful new tools provide unprecedented opportunities for understanding the cell types, molecules, and cell- cell interactions that contribute to chronic pain. The Multi-omics Core will be led by Dr. Renthal and centralizes the single-cell transcriptomic, epigenomic, and next-generation sequencing efforts with an experienced team in both the development, optimization, and analysis of single-cell and next-generation sequencing efforts. The centralization of these cutting-edge technologies will ensure that the established protocols can be applied systematically to all samples from the Center. Specifically, the Core will provide single-cell and single-nucleus multi-omic services to characterize pain-related tissues in both Projects 1 and 2. They will then provide both Projects rapid next-generation sequencing services with 1-3 day turnaround times at cost. Finally, the Core will remain at the cutting-edge of the rapidly evolving field of single-cell genomics and continue to bring innovations that improve quality and reduce costs back to the Center. The Core will also coordinate with similar Cores across the U19 PRECISION Human Pain Network to reconcile protocols and best practices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation gene therapy for refractory pain
  • 批准号:
    10366881
  • 项目类别:
  • 资助金额:
    $71.19万
  • 财政年份:
    2022
  • 负责人:
    William Russell Renthal
  • 依托单位:
Administrative Core
  • 批准号:
    10594335
  • 项目类别:
  • 资助金额:
    $20.11万
  • 财政年份:
    2022
  • 负责人:
    William Russell Renthal
  • 依托单位:
Next Generation Gene Therapy for Refractory Pain
  • 批准号:
    10553126
  • 项目类别:
  • 资助金额:
    $71.15万
  • 财政年份:
    2022
  • 负责人:
    William Russell Renthal
  • 依托单位:
Project 1: Multi-omic characterization of human nociceptors
  • 批准号:
    10594336
  • 项目类别:
  • 资助金额:
    $42.39万
  • 财政年份:
    2022
  • 负责人:
    William Russell Renthal
  • 依托单位:
国内基金
海外基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
  • 批准号:
    70571028
  • 项目类别:
    面上项目
  • 资助金额:
    16.5万元
  • 批准年份:
    2005
  • 负责人:
    杨印生
  • 依托单位: